Clinical trial
Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy
NCT00293904 · Cytos Biotechnology AG, Industry · Completed
Key facts
| NCT number | NCT00293904 |
|---|---|
| Title | Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy |
| Official title | Safety, Immunogenicity and Clinical Efficacy of an Allergen Vaccine (CYT005-AllQbG10) in Subjects With Seasonal Rhinoconjunctivitis Due to Grass-Pollen Allergy |
| Lead sponsor | Cytos Biotechnology AG, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hypersensitivity |
| Intervention type | Biological |
| Interventions | CYT005-AllQbG10 |
| Enrollment | 36 |
| Start date | Feb 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Feb 20, 2006 |
| Last update posted | Sep 20, 2007 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: